Cosmos Pharmaceutical Corporation (PK) (CSMYF)
USOTC
Year End May 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Total Assets | 202.6B | 225.69B | 250.61B | 273.56B | 320.28B | 341.32B | 363.05B | 420.97B |
Total Current Assets | 70.91B | 73.75B | 78.07B | 80.39B | 114.15B | 125.13B | 115.47B | 137.09B |
Cash and Equivalents | 27.28B | 27.73B | 21.67B | 19.02B | 52.12B | 55.11B | 37.36B | 45.93B |
Total Non-Current Assets | 76.18B | 93.05B | 108.89B | 126.29B | 145.68B | 170.58B | 190.51B | 211.07B |
Total Liabilities | 126.42B | 132.64B | 141.72B | 147.27B | 174.61B | 170.74B | 172.55B | 209.9B |
Total Current Liabilities | 103.46B | 114.13B | 126.44B | 133.17B | 161.95B | 159.54B | 162.06B | 192.05B |
Total Non-Current Liabilities | 43.06B | 34.01B | 27.46B | 24.8B | 21.69B | 18.55B | 16.84B | 31.56B |
Total Equity | 76.18B | 93.05B | 108.89B | 126.29B | 145.68B | 170.58B | 190.51B | 211.07B |
Common Equity | 4.18B | 4.18B | 4.18B | 4.18B | 4.18B | 4.18B | 4.18B | 4.18B |
Retained Earnings | 67.75B | 84.58B | 100.43B | 117.83B | 137.19B | 162.07B | 181.95B | 202.49B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.